As an industry we are on the threshold of a new age. Gene therapy. Immunotherapy. RNAi therapy. These and other innovative technologies are poised to radically transform medicine in the 21st Century. The faster we can deliver on their promise, the sooner we as individuals, and as a nation, will benefit.
Key to maintaining the great leaps we have made to date is understanding that the competitive private sector system we have in place, while not perfect, is the reason we’ve come so far so fast.
For the sake of future generations it is important that we all advocate to maintain the pipeline of innovations that can move our most dreaded diseases from the medical books to the history books.